StonvexLoading…
StonvexStonvexStonvexCore line items from HL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.42B | $929.92M | $720.23M | $718.90M |
Operating Income | $514.79M | $106.28M | $-44.67M | $-12.44M |
Net Income | $321.71M | $35.80M | $-84.22M | $-37.35M |
EPS (Diluted) | $0.49 | $0.06 | $-0.14 | $-0.07 |
Total Assets | $3.56B | $2.98B | $3.01B | $2.93B |
Total Liabilities | $969.00M | $941.55M | $1.04B | $948.21M |
Cash & Equivalents | $241.56M | $26.87M | $106.37M | $104.74M |
Free Cash Flow OCF − CapEx | $310.25M | $3.79M | $-148.39M | $-59.49M |
Shares Outstanding | 655.77M | 622.53M | 605.67M | 557.34M |